Company Filing History:
Years Active: 2002-2003
Title: The Innovative Contributions of Pascale Bohaeck Overel
Introduction
Pascale Bohaeck Overel, located in Brussels, Belgium, is an accomplished inventor in the realm of cancer research. With a focus on tumor rejection antigens, she holds two notable patents highlighting her commitment to advancing medical science and treatment methodologies.
Latest Patents
Pascale's latest patents reflect her significant contributions to the field of oncology. The first patent describes a method for treating subjects using BAGE tumor rejection antigen precursors or tumor rejection antigens. This patent details a family of BAGE tumor rejection antigen precursors and the nucleic acid molecules that code for them, illustrating their potential diagnostic and therapeutic uses.
The second patent discusses isolated nucleic acid molecules encoding peptides that form complexes with MHC molecules HLA-Cw*1601, further emphasizing the significance of BAGE coding molecules. It also outlines various uses and applications of these coding sequences and tumor rejection antigen precursor molecules.
Career Highlights
Pascale Bohaeck Overel is currently associated with the Ludwig Institute for Cancer Research Limited, where her innovative spirit and research expertise contribute to advancements in cancer treatment. Throughout her career, she has demonstrated a strong commitment to understanding and combating cancer through innovative research and development.
Collaborations
Pascale collaborates closely with esteemed colleagues such as Claude Wildmann and Thierry R Boon-Falleur. Together, they work on projects that push the boundaries of cancer research and provide hope for new therapeutic options.
Conclusion
In conclusion, Pascale Bohaeck Overel's work is a testament to the power of innovation in the scientific community. Her contributions to the understanding and treatment of cancer through her patents have the potential to make a lasting impact on healthcare. As a prominent figure in her field, she continues to inspire future generations of researchers and inventors.